ETAP-Lab - Preclinical Efficacy CRO
Annelise Letourneur is an experienced professional in neuroscience and preclinical research, currently serving as Branch Manager and Neuroscience Study Director at ETAP-Lab since July 2017, focusing on preclinical study and in vivo management in stroke research. Prior to ETAP-Lab, Annelise was involved in health and life sciences business development at Caen Normandie Développement and conducted postdoctoral research at CNRS, specializing in MRI and two-photon microscopy for glioma imaging. Annelise has also contributed to academia as a temporary lecturer and researcher while completing a PhD in Molecular and Cellular Biology with a focus on neuroscience. Educational credentials include a Master of Business Administration from IAE Caen and Masters and PhD degrees from universities in Caen and New Brunswick, emphasizing expertise in neurobiology and research methodologies.
This person is not in any teams
ETAP-Lab - Preclinical Efficacy CRO
ETAP-Lab provides preclinical models and services in the fields of Dermatology, Stroke and Neurodegenerative Diseases. The company has strong expertise in the field of Dermatology research and offers a large portfolio of original in vivo rodent models such as chronic skin inflammation, ischemic ulceration, psoriasis, hyperkeratosis, wound healing, atopic dermatitis, actinic keratosis, skin cancer… ETAP-Lab is also leader in the field of preclinical stroke research with a unique model portfolio consisting of innovative and translational models proposed under the brand Strok@lliance. With more than 2 decades of experience, ETAP-Lab has become a best-in-class service provider for top tier Pharma, Medical device and Agri-food companies and obtained ISO9001:v2015 certification for all its preclinical services. ETAP-Lab is listening to the needs of their clients to offer the most suited solution for products evaluation. Thus, its team is able to develop and customize relevant animal models with high translational value that fit to specific goals, from the proof-of-concept to the early development. Feel free to contact us!